The role of continuous renal replacement therapy in the management of acute kidney injury associated with sinusoidal obstruction syndrome following hematopoietic cell transplantation
dc.contributor.author | Raina, Rupesh | |
dc.contributor.author | Abusin, Ghada A. | |
dc.contributor.author | Vijayaraghavan, Prashant | |
dc.contributor.author | Auletta, Jeffery J. | |
dc.contributor.author | Cabral, Linda | |
dc.contributor.author | Hashem, Hasan | |
dc.contributor.author | Vogt, Beth A. | |
dc.contributor.author | Cooke, Kenneth R. | |
dc.contributor.author | Abu‐arja, Rolla F. | |
dc.date.accessioned | 2018-03-07T18:24:59Z | |
dc.date.available | 2019-05-13T14:45:24Z | en |
dc.date.issued | 2018-03 | |
dc.identifier.citation | Raina, Rupesh; Abusin, Ghada A.; Vijayaraghavan, Prashant; Auletta, Jeffery J.; Cabral, Linda; Hashem, Hasan; Vogt, Beth A.; Cooke, Kenneth R.; Abu‐arja, Rolla F. (2018). "The role of continuous renal replacement therapy in the management of acute kidney injury associated with sinusoidal obstruction syndrome following hematopoietic cell transplantation." Pediatric Transplantation 22(2): n/a-n/a. | |
dc.identifier.issn | 1397-3142 | |
dc.identifier.issn | 1399-3046 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/142494 | |
dc.description.abstract | Maintaining fluid balance, preâ and postâ MAâ HCT is essential and usually requires frequent administration of diuretics. Hepatic sinusoidal obstructive syndrome is potentially lifeâ threatening, especially when associated with AKI and MOF. This study describes six patients who developed AKIâ associated SOS and diureticâ resistant FO who subsequently underwent CRRT using standardized management guidelines for fluid balance postâ HCT. Retrospective chart review was done for HCT patients between September 2011 and October 2013 at a tertiary care children’s hospital. Thirtyâ four patients underwent MAâ HCT in the study period. Six patients had SOS complicated by diureticâ resistant FO and underwent CRRT. Defibrotide was used in three patients. Median time on CRRT was 10.5Â days. Sixtyâ six percent (NÂ =Â 4 of 6) of patients had full resolution of SOS symptoms with a mortality rate of 34% (NÂ =Â 2 of 6). Among patients who had full recovery of SOS symptoms, one patient developed AKI, endâ stage renal diseases and underwent kidney transplantation 34â months postâ HCT. Thus, of six included patients, two died and one developed ESRD with only 50% (NÂ =Â 3 of 6) good outcome. Use of a standardized, evidenceâ based fluid balance protocol and early initiation of CRRT for HCTâ related AKI/SOS was associated with good outcomes. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | sinusoidal obstruction syndrome | |
dc.subject.other | hematopoietic cell transplant | |
dc.subject.other | acute kidney injury | |
dc.subject.other | continuous renal replacement therapy | |
dc.subject.other | fluid overload | |
dc.title | The role of continuous renal replacement therapy in the management of acute kidney injury associated with sinusoidal obstruction syndrome following hematopoietic cell transplantation | |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Pediatrics | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/142494/1/petr13139.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/142494/2/petr13139_am.pdf | |
dc.identifier.doi | 10.1111/petr.13139 | |
dc.identifier.source | Pediatric Transplantation | |
dc.identifier.citedreference | Kizilbash SJ, Kashtan CE, Chavers BM, Cao Q, Smith AR. Acute kidney injury and the risk of mortality in children undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2016; 22: 1264 â 1270. | |
dc.identifier.citedreference | Coppell JA, Richardson PG, Soiffer R, et al. Hepatic venoâ occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant. 2010; 16: 157 â 168. | |
dc.identifier.citedreference | Sutherland SM, Byrnes JJ, Kothari M, et al. AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions. Clin J Am Soc Nephrol. 2015; 10: 554 â 561. | |
dc.identifier.citedreference | Naples JC, Skeens MA, Auletta J, et al. Anicteric venoâ occlusive disease after hematopoietic stem cell transplantation in children. Bone Marrow Transplant. 2016; 51: 135 â 137. | |
dc.identifier.citedreference | Skeens MA, McArthur J, Cheifetz IM, et al. High variability in the reported management of hepatic venoâ occlusive disease in children after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2016; 22: 1823 â 1828. | |
dc.identifier.citedreference | Goldstein SL, Currier H, Graf C, Cosio CC, Brewer ED, Sachdeva R. Outcome in children receiving continuous venovenous hemofiltration. Pediatrics. 2001; 107: 1309 â 1312. | |
dc.identifier.citedreference | Wallhult E, Kenyon M, Liptrott S, et al. Management of venoâ occlusive disease: the multidisciplinary approach to care. Eur J Haematol. 2017; 98: 322 â 329. | |
dc.identifier.citedreference | Didsbury MS, Mackie FE, Kennedy SE. A systematic review of acute kidney injury in pediatric allogeneic hematopoietic stem cell recipients. Pediatr Transplant. 2015; 19: 460 â 470. | |
dc.identifier.citedreference | Rajpal JS, Patel N, Vogel RI, Kashtan CE, Smith AR. Improved survival over the last decade in pediatric patients requiring dialysis after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2013; 19: 661 â 665. | |
dc.identifier.citedreference | Sutherland SM, Goldstein SL, Alexander SR. The prospective pediatric continuous renal replacement therapy (ppCRRT) registry: a critical appraisal. Pediatr Nephrol. 2014; 29: 2069 â 2076. | |
dc.identifier.citedreference | Flores FX, Brophy PD, Symons JM, et al. Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group. Pediatr Nephrol. 2008; 23: 625 â 630. | |
dc.identifier.citedreference | Wonnacott R, Josephs B, Jamieson J. CRRT regional anticoagulation using citrate in the liver failure and liver transplant population. Crit Care Nurs Q. 2016; 39: 241 â 251. | |
dc.identifier.citedreference | Dalle JH, Giralt SA. Hepatic venoâ occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment. Biol Blood Marrow Transplant. 2016; 22: 400 â 409. | |
dc.identifier.citedreference | Richardson PG, Corbacioglu S, Ho VT, et al. Drug safety evaluation of defibrotide. Expert Opin Drug Saf. 2013; 12: 123 â 136. | |
dc.identifier.citedreference | Richardson PG, Cooke KR, Krishnan AY. Strategies for the management of hepatic venoâ occlusive disease in patients undergoing bone marrow transplant. Clin Adv Hematol Oncol. 2015; 13 ( Suppl 12 ). http://www.hematologyandoncology.net/files/2016/02/CAHO-Dec-Supp-1.pdf. | |
dc.identifier.citedreference | Carreras E, Diazâ Beya M, Rosinol L, Martinez C, Fernandezâ Aviles F, Rovira M. The incidence of venoâ occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transplant. 2011; 17: 1713 â 1720. | |
dc.identifier.citedreference | Basu RK, Zappitelli M, Brunner L, et al. Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int. 2014; 85: 659 â 667. | |
dc.identifier.citedreference | Michael M, Kuehnle I, Goldstein SL. Fluid overload and acute renal failure in pediatric stem cell transplant patients. Pediatr Nephrol. 2004; 19: 91 â 95. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.